Evidence map›Paper›PMID 40990187›Full record

ArticleSe pu = Chinese journal of chromatography2025

[Simultaneous determination of 38 indazole amides synthetic cannabinoids and 15 metabolites in wastewater by solid phase extraction-liquid chromatography-tandem mass spectrometry].

Zhe Yang, Li-Wei Jiang, Yi-di Wu, Rui Jia, Jian-Xia Lyu

Abstract readEnglish Abstract
In one paragraph

Article in Se pu = Chinese journal of chromatography, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zhe YangNational Anti-Drug Laboratory Beijing Regional Center,Beijing 100164,China.
Li-Wei JiangNational Anti-Drug Laboratory Beijing Regional Center,Beijing 100164,China.
Yi-di WuNational Anti-Drug Laboratory Beijing Regional Center,Beijing 100164,China.
Rui JiaNational Anti-Drug Laboratory Beijing Regional Center,Beijing 100164,China.
Jian-Xia LyuNational Anti-Drug Laboratory Beijing Regional Center,Beijing 100164,China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Synthetic cannabinoids (SCs), which are significantly more potent and efficacious than natural cannabis, are among the most widely abused new psychoactive substances. The emergence of the so-called first-generation SCs was followed by other SCs that eventually led to the development of eighth-generation indole/indazole amide-based SCs. Indeed, this entire category of SCs was added to the list of controlled substances on July 1, 2021. SCs can be disguised in various ways and are commonly sold in the form of electronic cigarette oil. SCs quickly enter the bloodstream through the lungs when smoked and are eventually excreted in the forms of precursors and metabolites in urine and feces following oxidation and metabolism, and finally enter the urban sewage system. SCs abuse can be studied and evaluated by analyzing SCs and their metabolites in municipal wastewater, thereby providing a practical reference. Therefore, methods for detecting SCs and their metabolites in wastewater need to be developed.In this study, a solid phase extraction (SPE)-liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was developed for the simultaneous determination of 38 indazole amide SCs and 15 metabolites in wastewater. Samples were treated using Oasis

Indexed as

AmidesCannabinoidsIndazolesSolid Phase ExtractionTandem Mass SpectrometryWastewaterWater Pollutants, ChemicalChromatography, LiquidAmidesCannabinoidsIndazolesWastewaterWater Pollutants, Chemicalliquid chromatography-tandem mass spectrometry (LC-MS/MS)metabolitessolid phase extraction (SPE)synthetic cannabinoids (SCs)wastewater

Identifiers

PMID40990187
PMCPMC12461507

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.